Tracking Cancer's next move: study maps treatment paths when First-Line drugs stop working
NCT ID NCT07407439
Summary
This study observes how patients with a common type of advanced breast cancer respond to standard first-line drug combinations and what treatments doctors choose next when those drugs stop working. It involves about 245 patients already receiving care, collecting their real-world treatment data and outcomes. The goal is to learn from actual clinical practice to help doctors and patients make better decisions about subsequent treatment options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-••••
Locations
-
Tianjin Medical University Cancer Insititute and Hospital
RECRUITINGTianjin, 300060, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.